Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 8.09% is 19% above its 5-year average of 6.77%, around the middle of its 5-year range (-32.58%–30.72%).
496.20% above its 12-month average of -2.04%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-05-31): -8.11%.
GROSS MARGIN
8.09%
GROSS MARGIN AVG TTM
-2.04%
GROSS MARGIN AVG 3Y
5.29%
GROSS MARGIN AVG 5Y
6.77%
GROSS MARGIN AVG 10Y
16.27%
GROSS MARGIN AVG 15Y
23.45%
GROSS MARGIN AVG 20Y
28.98%
CURRENT VS TTM AVG
+496.20%
CURRENT VS 3Y AVG
+53.03%
CURRENT VS 5Y AVG
+19.46%
CURRENT VS 10Y AVG
-50.27%
CURRENT VS 15Y AVG
-65.50%
CURRENT VS 20Y AVG
-72.09%
SECTOR MEDIAN · HEALTHCARE
42.76%
median of 562 covered companies
CURRENT VS SECTOR MEDIAN
-81.08%
vs the sector median at left
Market Cap
$6.04M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-2.09%
Market Cap
$6.04M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
83.33%
Market Cap
$6.53M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.82M
Gross Margin
-1.29%
TTM Avg
-3.77%
3Y Avg
16.02%
5Y Avg
20.70%
Market Cap
$6.65M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.55M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.22M | 8.09% | -2.04% | 5.29% | 6.77% |
| Femasys Inc. (FEMY)vs › | $6.22M | 61.96% | 64.25% | 64.10% | 65.91% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.04M | 0.00% | 0.00% | 0.00% | -2.09% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.04M | 100.00% | 100.00% | 100.00% | 83.33% |
| Lucyd, Inc (LUCY)vs › | $5.92M | 22.79% | 17.23% | 3.90% | 1.13% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.82M | -1.29% | -3.77% | 16.02% | 20.70% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.65M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.86M | -291.27% | -237.54% | -120.88% | -89.07% |
Gross Margin
8.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-05-31 | -8.11% |
| 2026-02-28 | -4.46% |
| 2025-11-30 | 4.21% |
| 2025-08-31 | 30.72% |
| 2025-05-31 | -32.58% |
| 2025-02-28 | 1.70% |
| 2024-11-30 | 26.71% |
| 2024-08-31 | 15.99% |
| 2024-05-31 | 1.79% |
| 2024-02-29 | -14.65% |
| 2023-11-30 | 20.74% |
| 2023-08-31 | 24.05% |
| 2023-05-31 | 2.60% |
| 2023-02-28 | 10.82% |
| 2022-11-30 | 23.74% |
| 2022-08-31 | -3.36% |
| 2022-05-31 | 11.72% |
| 2022-02-28 | 21.84% |
| 2021-11-30 | 16.61% |
| 2021-08-31 | -7.05% |
| 2021-05-31 | -0.84% |
| 2021-02-28 | -2.02% |
| 2020-11-30 | 22.49% |
| 2020-08-31 | 10.32% |
| 2020-05-31 | 26.92% |
| 2020-02-29 | 18.01% |
| 2019-11-30 | 29.37% |
| 2019-08-31 | 30.75% |
| 2019-05-31 | 15.51% |
| 2019-02-28 | 29.01% |
| 2018-11-30 | 27.19% |
| 2018-08-31 | 26.49% |
| 2018-05-31 | 23.73% |
| 2018-02-28 | 33.83% |
| 2017-11-30 | 31.37% |
| 2017-08-31 | 35.62% |
| 2017-05-31 | 30.27% |
| 2017-02-28 | 29.96% |
| 2016-11-30 | 38.87% |
| 2016-08-31 | 40.92% |
| 2016-05-31 | 26.10% |
| 2016-02-29 | 25.30% |
| 2015-11-30 | 35.37% |
| 2015-08-31 | 32.74% |
| 2015-05-31 | 31.16% |
| 2015-02-28 | 35.31% |
| 2014-11-30 | 27.10% |
| 2014-08-31 | 29.96% |
| 2014-05-31 | 34.23% |
| 2014-02-28 | 38.76% |
| 2013-11-30 | 27.35% |
| 2013-08-31 | 25.68% |
| 2013-05-31 | 32.71% |
| 2013-02-28 | 31.44% |
| 2012-11-30 | 40.83% |
| 2012-08-31 | 43.02% |
| 2012-05-31 | 35.44% |
| 2012-02-29 | 37.42% |
| 2011-11-30 | 41.28% |
| 2011-08-31 | 36.69% |
| 2011-07-29 | 27.72% |
| 2011-02-28 | 37.11% |
| 2010-11-30 | 25.89% |
| 2010-08-31 | 33.01% |
| 2010-05-31 | 32.43% |
| 2010-02-28 | 36.00% |
| 2009-11-30 | 19.69% |
| 2009-08-31 | 32.78% |
| 2009-05-31 | 34.48% |
| 2009-02-28 | 49.08% |
| 2008-11-30 | 29.70% |
| 2008-08-31 | 44.64% |
| 2008-05-31 | 41.74% |
| 2008-02-29 | 39.74% |
| 2007-11-30 | 47.33% |
| 2007-08-31 | 45.11% |
| 2007-05-31 | 44.91% |
| 2007-02-28 | 36.25% |
| 2006-11-30 | 38.92% |
| 2006-08-31 | 32.57% |
| 2006-05-31 | 34.67% |
| 2006-02-28 | 34.93% |
| 2005-11-30 | 33.61% |
| 2005-08-31 | 31.96% |
| 2005-05-31 | 33.12% |
| 2005-02-28 | 33.30% |
| 2004-11-30 | 33.92% |
| 2004-08-31 | 31.04% |
| 2004-05-31 | 35.32% |
| 2004-02-29 | 33.20% |
| 2003-11-30 | 29.02% |
| 2003-08-31 | 30.53% |
| 2003-05-31 | 35.24% |
| 2003-02-28 | 31.80% |
| 2002-11-30 | 28.95% |
| 2002-08-31 | 31.35% |
